As of 2024-12-12, the Intrinsic Value of Sourcebio International PLC (SBI.L) is
156.22 GBP. This SBI.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 115.00 GBP, the upside of Sourcebio International PLC is
35.80%.
The range of the Intrinsic Value is 129.54 - 199.68 GBP
156.22 GBP
Intrinsic Value
SBI.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
129.54 - 199.68 |
156.22 |
35.8% |
| DCF (Growth 10y) |
132.05 - 197.03 |
156.95 |
36.5% |
| DCF (EBITDA 5y) |
145.41 - 175.29 |
155.86 |
35.5% |
| DCF (EBITDA 10y) |
142.99 - 181.67 |
158.20 |
37.6% |
| Fair Value |
444.91 - 444.91 |
444.91 |
286.88% |
| P/E |
316.42 - 504.43 |
412.06 |
258.3% |
| EV/EBITDA |
302.01 - 404.65 |
330.23 |
187.2% |
| EPV |
354.74 - 504.00 |
429.37 |
273.4% |
| DDM - Stable |
103.63 - 218.89 |
161.26 |
40.2% |
| DDM - Multi |
69.14 - 119.71 |
88.18 |
-23.3% |
SBI.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
71.61 |
| Beta |
1.06 |
| Outstanding shares (mil) |
0.62 |
| Enterprise Value (mil) |
72.52 |
| Market risk premium |
5.98% |
| Cost of Equity |
10.17% |
| Cost of Debt |
4.29% |
| WACC |
9.25% |